Which of the following conditions is primarily associated with stasis as a cause of thrombosis?
All are true regarding lupus anticoagulant except?
Mr. Lallu, aged 54 years, who is a known diabetic patient, develops cirrhosis. There is associated skin hyperpigmentation and restrictive cardiomyopathy. Which of the following is the best initial test to diagnose this case?
A 20-year-old male presented with fatigue, weakness, and jaundice. What is the most likely diagnosis?
A 25-year-old lady on treatment for rheumatoid arthritis has the following laboratory findings: hemoglobin of 9 g/dL, mean corpuscular volume of 55 fl, serum iron of 30 μg/dL, ferritin of 200 ng/mL, and total iron-binding capacity of 298 μg/dL. What is the most probable diagnosis?
Which of the following statements is true regarding von Willebrand disease?
Which of the following statements about cold agglutinin disease is false?
A middle-aged male presented with a history of fatigue and tiredness. On investigation, he had a hemoglobin level of 8 g/dL and a mean corpuscular volume (MCV) of 110 fl, with the peripheral smear showing macrocytes and hypersegmented neutrophils. Which of the following is the most likely cause of these findings in this patient?
Hemolytic anemia is associated with which gallstones?
Bone marrow biopsy is absolutely indicated in which of the hematological conditions?
Explanation: ***All of the above*** - Stasis can contribute to **thrombosis in various conditions**, including polycythemia, as it increases blood viscosity, and in sickle cell anemia due to impaired blood flow [2]. - **Venous circulation** is particularly affected by stasis, as it leads to venous thromboembolism, making it a critical factor in thrombosis [1]. *Polycythemia* - While **polycythemia** leads to increased blood viscosity, stasis itself isn't the primary mechanism for thrombosis in this condition. - Thrombosis in polycythemia is more due to *hyperviscosity* rather than stasis alone. *Venous circulation* - While stasis is indeed significant in **venous circulation**, it does not capture the full spectrum of thrombosis causes in the context of various conditions [1]. - Other factors such as **hypercoagulability** and **vascular injury** also contribute, making it not solely reliant on stasis [1]. *Sickle cell Anemia* - Thrombosis in sickle cell anemia occurs mainly due to **occlusion** from sickled cells, rather than stasis leading to thrombus formation [2]. - While stasis can occur, it is not the principal cause of thrombosis in this disease [2].
Explanation: ***Thrombocytosis*** - **Lupus anticoagulant** is associated with an **increased risk of thrombosis**, but it does not directly cause thrombocytosis (an elevated platelet count). - Patients with **antiphospholipid syndrome**, which involves lupus anticoagulant, can have normal or even low platelet counts (**thrombocytopenia**). [1] *Increased antibodies* - **Lupus anticoagulant** is an **autoantibody** (specifically, an antiphospholipid antibody) that interferes with coagulation tests in vitro, but it is associated with an increased risk of thrombosis in vivo. - The presence of this antibody is a key diagnostic criterion for **antiphospholipid syndrome**. *Rashes* - **Lupus anticoagulant** is often found in patients with **systemic lupus erythematosus (SLE)**, a condition known for various skin manifestations, including characteristic rashes (e.g., **malar rash**, discoid rash). [1] - While not directly caused by lupus anticoagulant, it is highly associated given the overlap between **SLE and antiphospholipid syndrome**. *Arterial thrombosis* - **Lupus anticoagulant** is a significant risk factor for both **arterial and venous thrombosis**, leading to complications like strokes, myocardial infarctions, and peripheral arterial occlusions. - It contributes to a **prothrombotic state** by activating endothelial cells and interfering with natural anticoagulant pathways.
Explanation: ***Serum ferritin*** - Elevated **serum ferritin** is an excellent initial screening test for **hemochromatosis** due to its direct correlation with iron stores [1]. - The constellation of **cirrhosis**, **diabetes**, **skin hyperpigmentation**, and **restrictive cardiomyopathy** strongly points to hemochromatosis, a disorder of excessive iron accumulation [2]. *Serum ceruloplasmin* - This test is primarily used for diagnosing **Wilson's disease**, which involves copper accumulation, not iron. - While Wilson's can cause cirrhosis, the other symptoms (diabetes and skin hyperpigmentation) are not typical for this condition. *Serum copper* - **Serum copper** is another test for Wilson's disease or other copper metabolism disorders. - It does not directly assess iron stores and would not be the best initial test for suspected hemochromatosis. *Iron binding capacity* - **Total iron-binding capacity (TIBC)** measures the blood's capacity to bind iron, primarily reflecting transferrin levels. - While relevant to iron metabolism, **serum ferritin** is a more sensitive and specific initial screening test for diagnosing iron overload in hemochromatosis.
Explanation: ***Acute myeloid leukemia*** - Presents with **fatigue** and **weakness** due to bone marrow infiltration and resultant cytopenias, typical in this age group [1]. - Often shows **myeloblasts** on peripheral blood smear, confirming the diagnosis [2]. *Chronic myeloid leukemia* - Usually occurs in **older adults** and characterized by **elevated white blood cell counts** with a predominance of mature neutrophils. - Symptoms like fatigue may arise, but there are distinct **Philadelphia chromosome** findings and typically a **longer symptom duration**. *Acute lymphoblastic leukemia* - More common in **younger children** and often associated with **lymphadenopathy** and **thrombocytopenia**, rather than fatigue alone. - Characteristically shows **lymphoblasts** in the blood, which are not mentioned in this patient's presentation. *Chronic lymphocytic leukemia* - Typically presents in adults over **50 years** and is characterized by **lymphocytosis** and often asymptomatic in early stages. - Fatigue may occur but lacks the acute presentation and findings seen in **acute leukemias**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 607-608. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 621-622.
Explanation: **Thalassemia minor** - The combination of **microcytic anemia (MCV 55 fL)**, **low serum iron (30 μg/dL)**, **normal to elevated ferritin (200 ng/mL)**, and a **normal-to-high total iron-binding capacity (298 μg/dL)** suggests a condition where iron stores are adequate but incorporation into hemoglobin is impaired. - This is characteristic of **thalassemia trait**, where genetic defects lead to reduced synthesis of globin chains despite sufficient iron, causing microcytic, hypochromic red blood cells. *Thalassemia major* - Patients with **thalassemia major** typically present with severe anemia requiring frequent transfusions and would likely have much lower hemoglobin levels and often associated with markers of severe hemolysis. - While it causes **microcytic anemia**, the clinical picture and iron studies (especially relatively high ferritin and only moderately low hemoglobin) are less consistent with overt thalassemia major. *Anemia of chronic disease* - **Anemia of chronic disease (ACD)** typically presents with **normal or elevated ferritin** and a **low serum iron**, but usually has a **normal MCV** (normocytic anemia) or, sometimes, mild microcytosis [1]. - The MCV of 55 fL is too low to be classic ACD, and typically TIBC would be low in ACD due to inflammation [2]. *Iron deficiency anemia* - **Iron deficiency anemia** typically presents with **low serum iron**, **low ferritin**, and a **high total iron-binding capacity** due to the body's attempt to absorb more iron [2]. - The **elevated ferritin (200 ng/mL)** in this case makes isolated iron deficiency anemia highly unlikely, as ferritin is a measure of iron stores.
Explanation: Normal prothrombin time (PT) - In von Willebrand disease, **PT remains normal**, which indicates that the extrinsic pathway of coagulation is unaffected [1]. - This disorder primarily affects **platelet function** and vWF levels, not prothrombin time. *Platelet count may be decreased in some cases* - While platelet count can be low, it is not a consistent finding in von Willebrand disease; often, **platelet count is normal**. - The disorder primarily involves **qualitative abnormalities** in platelets due to impaired vWF function, rather than quantitative [3]. *Bleeding time is prolonged* - Bleeding time is typically **prolonged** in von Willebrand disease, which reflects platelet dysfunction, but this statement does not correctly state its context. - The disease affects **hemostasis**, leading to increased bleeding tendencies rather than maintaining normal bleeding times. *Normal activated partial thromboplastin time (aPTT)* - In von Willebrand disease, **aPTT may be prolonged** due to the deficiency of factor VIII, which is carried by vWF [2]. - The presence of normal aPTT does not reflect the disease's impact on the intrinsic pathway of coagulation.
Explanation: ***Rituximab is not effective as a therapeutic measure as it can not control hemolysis effectively*** - This statement is **false**. **Rituximab** is a **monoclonal antibody** targeting CD20 on B-lymphocytes, and it is an **effective treatment** for cold agglutinin disease, especially in chronic cases [1]. - By depleting the B-cells responsible for producing the cold agglutinins (autoantibodies), rituximab can significantly **reduce hemolysis** and improve patient outcomes [1]. *The antibody is usually IgM with an anti-I specificity* - This statement is **true**. Cold agglutinins are typically **IgM autoantibodies** that react optimally at temperatures below 37°C [1]. - They most commonly target the **I antigen** on the surface of red blood cells, leading to agglutination and hemolysis when exposed to cold temperatures [1]. *Blood transfusion is not very effective because donor red cells are I-positive and will be rapidly removed* - This statement is **true**. Most individuals, including blood donors, have **I-positive red blood cells**. - Therefore, transfused red blood cells will also carry the I antigen and be susceptible to destruction by the patient's cold agglutinins, making transfusions less effective and potentially risky. *Hemolysis is more prominent the more the body is exposed to the cold* - This statement is **true**. The defining characteristic of cold agglutinin disease is the **temperature-dependent activity** of the autoantibodies [1]. - Exposure to **colder temperatures** increases the binding of IgM antibodies to red blood cells, leading to more extensive agglutination, complement activation, and subsequent hemolysis [1].
Explanation: ***Chronic alcoholism*** - **Macrocytic anemia** with a **hemoglobin level of 8 g/dL** is commonly seen in chronic alcoholism due to impaired erythropoiesis and folate deficiency. [1] - The **peripheral smear** showing **hypersegmented neutrophils** is indicative of megaloblastic anemia, often linked to **alcoholism**. [1] *Chronic renal failure* - Typically causes **normocytic anemia** due to inadequate erythropoietin production, not macrocytic anemia. [2] - While uremic effects can impact erythropoiesis, they usually do not produce **hypersegmented neutrophils** found in megaloblastic anemia. *Colon cancer* - More commonly causes **microcytic anemia** due to **iron deficiency** from chronic blood loss rather than macrocytic anemia. [2] - **Macrocytic anemia** with hypersegmented neutrophils would not be expected in most cases of colon cancer. *Ancylostoma duodenale infestation* - This hookworm infection typically leads to **microcytic anemia** due to **iron deficiency**, not macrocytic. [2] - The presence of **macrocytes** and **hypersegmented neutrophils** does not correlate with this type of anemia.
Explanation: ***Pigmented*** - **Pigmented gallstones** (specifically black pigment stones) are associated with hemolytic anemia due to increased **unconjugated bilirubin** production [1]. - The excess bilirubin is excreted into bile, where it polymerizes with calcium to form insoluble calcium bilirubinate, leading to stone formation [1]. *Cholesterol* - **Cholesterol gallstones** are the most common type and are primarily formed from supersaturated cholesterol in bile [1]. - Their formation is not directly linked to conditions causing increased bilirubin production, such as **hemolytic anemia**. *Mixed* - **Mixed gallstones** contain both cholesterol and calcium bilirubinate but are predominantly cholesterol [1]. - While they may contain some pigment, their primary etiology is related to gallbladder stasis and cholesterol supersaturation, not typically **hemolysis**. *None of the options* - This option is incorrect because **pigmented gallstones** are strongly associated with hemolytic anemia.
Explanation: ***Hairy cell leukemia*** - A **bone marrow biopsy** is absolutely indicated for diagnosis due to the characteristic **fibrosis** that often prevents a diagnostic aspirate. - The biopsy can reveal infiltration by "hairy cells" and assess the extent of disease and **myelofibrosis**. *Acute leukemia* - While bone marrow examination (aspirate and biopsy) is crucial for diagnosing **acute leukemia**, an aspirate is often sufficient for initial diagnosis and classification. - Biopsy provides additional information on cellularity and architecture, but the diagnosis can often be made on the aspirate. *Megaloblastic anemia* - Diagnosis primarily relies on **peripheral blood smears** showing macro-ovalocytes and hypersegmented neutrophils, along with **serum vitamin B12** and **folate levels**. - A bone marrow aspirate can show **megaloblastic erythroid and myeloid hyperplasia**, but it is generally not an absolute indication for diagnosis. *Thalassemia* - Diagnosis of **thalassemia** is primarily based on **hemoglobin electrophoresis**, genetic testing, and peripheral blood indices (microcytic, hypochromic anemia). - Bone marrow examination is usually not required for diagnosis, though it may show erythroid hyperplasia.
Anemia Evaluation and Management
Practice Questions
Hemoglobinopathies
Practice Questions
Thalassemias
Practice Questions
Platelet Disorders
Practice Questions
Coagulation Disorders
Practice Questions
Thrombotic Disorders
Practice Questions
Leukemias
Practice Questions
Lymphomas
Practice Questions
Multiple Myeloma and Plasma Cell Disorders
Practice Questions
Myeloproliferative Neoplasms
Practice Questions
Transfusion Medicine
Practice Questions
Hematopoietic Stem Cell Transplantation
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free